Mereo BioPharma (MREO) Current Leases (2018 - 2025)
Mereo BioPharma (MREO) posted quarterly Current Leases of $202000.0 for Q4 2025, down 71.43% year-on-year from $707000.0 in Q4 2024, and down 49.12% on a QoQ basis from $397000.0 in Q3 2025.
Mereo BioPharma (MREO) Current Leases (2018 - 2025) Analysis & Trends
Mereo BioPharma (MREO) has reported Current Leases for 8 consecutive years, with $202000.0 the latest figure, recorded in Q4 2025.
- Quarterly Current Leases fell 71.43% year-over-year to $202000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $202000.0 (down 71.43% YoY) and the FY2025 annual result came in at $202000.0, down 71.43% from the prior year.
- Current Leases declined to $202000.0 in Q4 2025 per MREO's latest filing, from $397000.0 in the prior quarter.
- Over the last five years, Current Leases for MREO reached as high as $1.0 million in Q2 2021 and fell as low as $202000.0 in Q4 2025.
- A 5-year average of $651505.0 and a median of $670500.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases advanced 19.29% — and 2025, when it tumbled 71.43%.
- Year by year, Current Leases stood at $838462.6 in 2021, then slumped by 34.81% to $546584.6 in 2022, then gained by 19.29% to $652000.0 in 2023, then rose by 8.44% to $707000.0 in 2024, then slumped by 71.43% to $202000.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $202000.0, $397000.0, and $601000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 202,000.00 |
| Sep 30, 2025 | 397,000.00 |
| Jun 30, 2025 | 601,000.00 |
| Mar 31, 2025 | 747,000.00 |
| Dec 31, 2024 | 707,000.00 |
| Sep 30, 2024 | 736,000.00 |
| Jun 30, 2024 | 679,000.00 |
| Mar 31, 2024 | 662,000.00 |
| Dec 31, 2023 | 652,000.00 |
| Jun 30, 2023 | 610,665.22 |
| Dec 31, 2022 | 546,584.60 |
| Jun 30, 2022 | 730,402.24 |
| Dec 31, 2021 | 838,462.60 |
| Jun 30, 2021 | 1.01 Mn |
| Dec 31, 2020 | 839,806.84 |
| Jun 30, 2020 | 1.11 Mn |
| Dec 31, 2019 | 3.32 Mn |
| Dec 31, 2018 | 781,067.71 |